Evidence map›Paper›PMID 26024074›Full record

ArticleInvestigative ophthalmology & visual science2015

Progesterone treatment in two rat models of ocular ischemia.

Rachael S Allen, Timothy W Olsen, Iqbal Sayeed, Heather A Cale, Katherine C Morrison, Yuliya Oumarbaeva, Irina Lucaciu, Jeffrey H Boatright, Machelle T Pardue, Donald G Stein

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Neuroprotective strategies for retinal disease.Progress in retinal and eye research · 2018
    Review
  18. Does progesterone have protective effects on ovarian ischemia-reperfusion injury?Journal of the Turkish German Gynecological Association · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rachael S AllenEmergency Medicine Emory University, Atlanta, Georgia, United States 2Department of Ophthalmology, Emory University, Atlanta, Georgia, United States 3Atlanta VA Center for Visual and Neurocognitive Rehabilitation, Decatur, Georgia, United States.
Timothy W OlsenDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States.
Iqbal SayeedEmergency Medicine Emory University, Atlanta, Georgia, United States.
Heather A CaleEmergency Medicine Emory University, Atlanta, Georgia, United States.
Katherine C MorrisonEmergency Medicine Emory University, Atlanta, Georgia, United States.
Yuliya OumarbaevaEmergency Medicine Emory University, Atlanta, Georgia, United States.
Irina LucaciuEmergency Medicine Emory University, Atlanta, Georgia, United States.
Jeffrey H BoatrightDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States 3Atlanta VA Center for Visual and Neurocognitive Rehabilitation, Decatur, Georgia, United States.
Machelle T PardueDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States 3Atlanta VA Center for Visual and Neurocognitive Rehabilitation, Decatur, Georgia, United States.
Donald G SteinEmergency Medicine Emory University, Atlanta, Georgia, United States.
Emory University · USAtlanta VA Health Care System · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
Transscleral Drug Delivery for Retinal DisordersR24EY017045 · NEI · EMORY UNIVERSITY · PI EDELHAUSER, HENRY FRANCIS · 2006 to 2010
$6.9M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Oligonucleotide Repair of a Retinal Degeneration ModelR01EY014026 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 2004 to 2015
$4.1M
Gene Delivery in Retinal DiseasesR01EY016470 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 2006 to 2015
$3.2M
NEI NIH HHS P30 EY006360NEI NIH HHS P30EY006360NEI NIH HHS R01 EY014026NEI NIH HHS R01EY014026NEI NIH HHS R01 EY016470NEI NIH HHS R01EY016470NEI NIH HHS R24 EY017045NEI NIH HHS R24EY017045NEI NIH HHS T32 EY007092NEI NIH HHS T32EY007092-24
6 · The paper itself

Abstract

purposeTo determine whether the neurosteroid progesterone, shown to have protective effects in animal models of traumatic brain injury, stroke, and spinal cord injury, is also protective in ocular ischemia animal models.

methodsProgesterone treatment was tested in two ocular ischemia models in rats: a rodent anterior ischemic optic neuropathy (rAION) model, which induces permanent monocular optic nerve stroke, and the middle cerebral artery occlusion (MCAO) model, which causes transient ischemia in both the retina and brain due to an intraluminal filament that blocks the ophthalmic and middle cerebral arteries. Visual function and retinal histology were assessed to determine whether progesterone attenuated retinal injury in these models. Additionally, behavioral testing and 2% 2,3,5-triphenyltetrazolium chloride (TTC) staining in brains were used to compare progesterone's neuroprotective effects in both retina and brain using the MCAO model.

resultsProgesterone treatment showed no effect on visual evoked potential (VEP) reduction and retinal ganglion cell loss in the permanent rAION model. In the transient MCAO model, progesterone treatment reduced (1) electroretinogram (ERG) deficits, (2) MCAO-induced upregulation of glutamine synthetase (GS) and glial fibrillary acidic protein (GFAP), and (3) retinal ganglion cell loss. As expected, progesterone treatment also had significant protective effects in behavioral tests and a reduction in infarct size in the brain.

conclusionsProgesterone treatment showed protective effects in the retina following MCAO but not rAION injury, which may result from mechanistic differences with injury type and the therapeutic action of progesterone.

Indexed as

AnimalsCell DeathDisease Models, AnimalDrug Evaluation, PreclinicalElectroretinographyEvoked Potentials, VisualInfarction, Middle Cerebral ArteryIschemiaMaleNeuroprotective AgentsOptic Neuropathy, IschemicProgesteroneRats, Sprague-DawleyRetinal Ganglion CellsRetinal VesselsNeuroprotective AgentsProgesterone

Identifiers

PMID26024074
PMCPMC4419778
OpenAlexW2397747293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.